# Bimatoprost

## Lumigan PF eye drops 0.03% 0.4mL

| TAH Drug Code      | [ELUMI](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=ELUMI)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:-------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Open-angle glaucoma and ocular hypertension. Note: LUMIGAN is indicated for patients with open-angle glaucoma or ocular hypertension who are intolerant of other intraocular pressure-lowering medications or have insufficient response to them (inability to achieve target intraocular pressure measurements over time), to reduce elevated intraocular pressure.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| Dosing             | 1 drop at night in the affected eye, once daily only, as increased dosing may reduce effectiveness. Onset: About 4 hours with peak effect in 8-12 hours. Can be used with other eye meds, spaced 5 minutes apart if multiple.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Contraindications  | Hypersensitivity to bimatoprost or any component of the product.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| Adverse Effects    | >10%: Ophthalmic: Conjunctival hyperemia (Latisse: <4%; Lumigan: <=45%), eye pruritus (Latisse, Lumigan 0.01%: <=4%; Lumigan 0.03%: 15% to 45%), hypertrichosis of eyelid (Lumigan 0.01%: 1% to 4%; Lumigan 0.03%: 15% to 45%) 1% to 10%: Dermatologic: Erythema of skin (Latisse, Lumigan [including periorbital]), hypertrichosis (1% to 4%) Endocrine & metabolic: Hirsutism (Latisse, Lumigan: 1% to 5%) Hepatic: Abnormal hepatic function tests (1% to 5%) Local: Local skin hyperpigmentation (Latisse, Lumigan [including periocular]) Nervous system: Asthenia (1% to 5%), headache (1% to 5%) Ophthalmic: Allergic conjunctivitis (1% to 3%), asthenopia (1% to 3%), blepharitis (3% to 10%), blurred vision (1% to 4%), burning sensation of eyes (3% to 10%), cataract (3% to 10%), conjunctival edema (1% to 4%), conjunctival hemorrhage (1% to 4%), decreased visual acuity (1% to 4%), dry eye syndrome (Latisse, Lumigan), erythema of eyelid (1% to 4%), eye discharge (1% to 3%), eye irritation (Latisse, Lumigan), eye pain, eyelid pruritus (Latisse, Lumigan: 1% to 4%), foreign body sensation of eye (Latisse, Lumigan: 3% to 10%), hyperpigmentation of eyelashes (3% to 10%), iris hyperpigmentation (Latisse, Lumigan: 1% to 3%), lacrimation (1% to 3%), photophobia (1% to 3%), punctate keratitis (1% to 4%), superficial punctate keratitis (3% to 10%), visual disturbance (3% to 10%) <1%: Ophthalmic: Iritis Frequency not defined (any formulation): Ophthalmic: Hypotony of eye Postmarketing (any formulation): Cardiovascular: Hypertension Dermatologic: Allergic dermatitis, erythematous rash, macular eruption, skin discoloration (including periorbital, non-periorbital), skin tightness (periorbital), trichorrhexis, xeroderma (eyelid) Gastrointestinal: Nausea Hypersensitivity: Hypersensitivity reaction Local: Local dryness of skin (periocular), local hypersensitivity reaction, local skin exfoliation (periorbital) Nervous system: Dizziness Ophthalmic: Abnormal eyelash growth (madarosis), blepharoptosis, deepening of the eyelid sulcus, endophthalmitis, enophthalmos, eyelid edema, eyelid entropion, eyelid retraction, hordeolum, hyperpigmentation of eyelid, increased lacrimation, intraocular inflammation, macular edema (including cystoid macular edema), misdirected growth of eyelashes, ocular allergy, ocular edema, periorbital swelling, scaling of eyelid Respiratory: Dyspnea, pulmonary signs and symptoms (asthma-like) |
| Pregnancy          | No (Limited) Human Data – Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| Lactation          | No (Limited) Human Data - Probably Compatible                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| More Info          | [UpToDate](https://www.uptodate.com/contents/bimatoprost-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |

